30.10.2014 Views

Click here to view as PDF - MICROmanufacturing

Click here to view as PDF - MICROmanufacturing

Click here to view as PDF - MICROmanufacturing

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

New Life<br />

Advances in l<strong>as</strong>er machining key <strong>to</strong> stent market growth<br />

By Daniel McCann, Senior Edi<strong>to</strong>r<br />

A l<strong>as</strong>er-cut and expanded stent from SAES Memry undergoes optical inspection.<br />

The coronary stent industry—the one-time<br />

medical device juggernaut that posted double-digit<br />

growth just 5 years ago, then swiftly<br />

dove in<strong>to</strong> a double-digit tailspin—is making a<br />

comeback. After 2 years of near-stagnation due<br />

<strong>to</strong> concerns about safety and overuse, which<br />

have been addressed (see sidebar, page 38), the<br />

$1.8 billion stent market posted a 3 percent gain<br />

in 2009, said Venkat Rajan, medical devices manager<br />

at market research firm Frost & Sullivan,<br />

San An<strong>to</strong>nio.<br />

While that’s positive news for stent manufacturers,<br />

significant challenges remain. And<br />

l<strong>as</strong>er machining technology promises <strong>to</strong> play<br />

an incre<strong>as</strong>ingly key role in helping them meet<br />

those challenges.<br />

Competition and innovation<br />

In 2000, Cordis Corp., a Johnson & Johnson<br />

company b<strong>as</strong>ed in Miami Lakes, Fla., and Bos<strong>to</strong>n<br />

Scientific Corp., Natick, M<strong>as</strong>s., were the<br />

sole suppliers of U.S. Food and Drug Administration-approved<br />

drug-eluting stents. (Ninety<br />

percent of stents sold are DES vs. 10 percent<br />

bare metal.) Today, the OEM competitive pool<br />

SAES Memry<br />

h<strong>as</strong> doubled, with Abbott V<strong>as</strong>cular, a division<br />

of Abbott Labora<strong>to</strong>ries, Abbott Park, Ill., and<br />

Medtronic Inc., Cleveland, bidding for a share<br />

of the profits with their FDA-cleared products.<br />

About 10 other companies are at work developing<br />

their own stents. Moreover, during the p<strong>as</strong>t<br />

10 years, dozens of contract manufacturers have<br />

entered the industry.<br />

To effectively compete in an incre<strong>as</strong>ingly<br />

crowded field, OEMs and contract manufacturers<br />

depend on continual technological innovation<br />

<strong>to</strong> lower costs, improve quality or both.<br />

According <strong>to</strong> Dan Capp, vice president of sales<br />

development for L<strong>as</strong>erage Technology Development<br />

Corp., Waukegan Ill., advances in l<strong>as</strong>er<br />

stent-cutting technology in recent years have focused<br />

on l<strong>as</strong>er workstation motion components,<br />

controllers (software) and the l<strong>as</strong>ers themselves.<br />

Built upon granite b<strong>as</strong>es, l<strong>as</strong>er workstations<br />

incorporate the l<strong>as</strong>er, linear-mo<strong>to</strong>r motion systems,<br />

direct-drive rotary axes, l<strong>as</strong>er control electronics,<br />

and CAD/CAM and control software.<br />

The stent-cutting operation starts with stainless<br />

steel, chrome-cobalt-alloy or Nitinol tubes with<br />

diameters ranging from 0.020" <strong>to</strong> 0.250" loaded<br />

micromanufacturing.com | 35

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!